Impact of pneumococcal vaccination in Senegalese HIV-1-infected children.
Dieye
Tandakha
T
Simonart
Thierry
T
Sow
Papa S
PS
M'Baye
Ngagne
N
M'Boup
Souleymane
S
Farber
Claire-Michèle
CM
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology* / Q000517:prevention & control*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003906:Developing Countries; D005260:Female; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007109:Immunity / Q000502:physiology; D008297:Male; D011008:Pneumococcal Infections / Q000276:immunology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D012016:Reference Values; D012675:Senegal; D014611:Vaccination; D019562:Viral Load
D022242:Pneumococcal Vaccines